{"doc_id": "PMC-1310901-04-MATERIALS_AND_METHODS-03.txt", "sent_id": "S1", "tokens": ["Sequencing", "of", "the", "IRF-4", "promoter"], "sentence": "Sequencing of the IRF-4 promoter", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "IRF-4", "entity_type": "Protein", "start": 3, "end": 3}]}
{"doc_id": "PMC-1310901-04-MATERIALS_AND_METHODS-03.txt", "sent_id": "S2", "tokens": ["For", "analysis", "of", "the", "IRF-4", "promoter", "region", "for", "permanent", "aberrations", "such", "as", "insertions", "/", "deletions", "or", "mutation", ",", "we", "PCR", "-", "amplified", "two", "fragments", "from", "genomic", "DNA", ",", "which", "was", "extracted", "from", "depicted", "cell", "lines", "with", "a", "commercial", "kit", "(", "Qiagen", ",", "Hilde", ",", "Germany", ")", "as", "recommended", "."], "sentence": "For analysis of the IRF-4 promoter region for permanent aberrations such as insertions / deletions or mutation , we PCR - amplified two fragments from genomic DNA , which was extracted from depicted cell lines with a commercial kit ( Qiagen , Hilde , Germany ) as recommended .", "event_mentions": [], "entity_mentions": [{"id": "T2", "text": "IRF-4", "entity_type": "Protein", "start": 4, "end": 4}]}
{"doc_id": "PMC-1310901-04-MATERIALS_AND_METHODS-03.txt", "sent_id": "", "tokens": ["The", "primers", "were", "1-forward", ":", "5'-TTGAGATGGAGTCTTGCTCTGT-3", "'", ",", "1-reverse", ":", "5'-CCAGGACCTCAGGAGGCCAGTCA-3", "'", ";", "2-forward", ":", "5'-AGCGGTGAAACTGAGAGTGCGAGGT-3", "'", ",", "2-reverse", ":", "5'-GCCACATCGCTGCAGTTTAG-3", "'", "."], "sentence": "The primers were 1-forward : 5'-TTGAGATGGAGTCTTGCTCTGT-3 ' , 1-reverse : 5'-CCAGGACCTCAGGAGGCCAGTCA-3 ' ; 2-forward : 5'-AGCGGTGAAACTGAGAGTGCGAGGT-3 ' , 2-reverse : 5'-GCCACATCGCTGCAGTTTAG-3 ' .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-04-MATERIALS_AND_METHODS-03.txt", "sent_id": "", "tokens": ["The", "products", "were", "cloned", "with", "the", "'TOPO", "TA", "cloning", "kit", "'", "(", "Invitrogen", ",", "Groningen", ",", "The", "Netherlands", ")", "."], "sentence": "The products were cloned with the 'TOPO TA cloning kit ' ( Invitrogen , Groningen , The Netherlands ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-04-MATERIALS_AND_METHODS-03.txt", "sent_id": "", "tokens": ["After", "bacterial", "amplification", "of", "the", "cloned", "PCR", "fragments", "by", "standard", "procedures", ",", "at", "least", "three", "clones", "from", "each", "sample", "were", "sequenced", "with", "an", "automated", "sequencer", "(", "ABI", "Prism", "377", ",", "Applied", "Bio-systems", ",", "Foster", "City", ",", "USA", ")", "as", "recommended", "by", "the", "manufacturer", "."], "sentence": "After bacterial amplification of the cloned PCR fragments by standard procedures , at least three clones from each sample were sequenced with an automated sequencer ( ABI Prism 377 , Applied Bio-systems , Foster City , USA ) as recommended by the manufacturer .", "event_mentions": [], "entity_mentions": []}
